Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.
Jiagge E, Jin DX, Newberg JY, Perea-Chamblee T, Pekala KR, Fong C, Waters M, Ma D, Dei-Adomakoh Y, Erb G, Arora KS, Maund SL, Njiraini N, Ntekim A, Kim S, Bai X, Thomas M, van Eeden R, Hegde P, Jee J, Chakravarty D, Schultz N, Berger MF, Frampton GM, Sokol ES, Carrot-Zhang J. Jiagge E, et al. Among authors: van eeden r. Cancer Cell. 2023 Nov 13;41(11):1963-1971.e3. doi: 10.1016/j.ccell.2023.10.003. Epub 2023 Oct 26. Cancer Cell. 2023. PMID: 37890492 Free article.
Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study.
Rapoport BL, Aapro M, Paesmans M, van Eeden R, Smit T, Krendyukov A, Klastersky J. Rapoport BL, et al. Among authors: van eeden r. BMC Cancer. 2018 Sep 24;18(1):917. doi: 10.1186/s12885-018-4838-z. BMC Cancer. 2018. PMID: 30249215 Free PMC article.
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials.
Banna GL, Signori A, Curioni-Fontecedro A, Cortellini A, Ponzano M, Giunta EF, Rebuzzi SE, Chan S, Gebbia V, van Eeden R, Addeo A, Ottensmeier C. Banna GL, et al. Among authors: van eeden r. Eur J Cancer. 2022 May;166:287-299. doi: 10.1016/j.ejca.2022.02.030. Epub 2022 Mar 28. Eur J Cancer. 2022. PMID: 35358809 Review.
Supportive care for patients undergoing immunotherapy.
Rapoport BL, van Eeden R, Sibaud V, Epstein JB, Klastersky J, Aapro M, Moodley D. Rapoport BL, et al. Among authors: van eeden r. Support Care Cancer. 2017 Oct;25(10):3017-3030. doi: 10.1007/s00520-017-3802-9. Epub 2017 Jul 13. Support Care Cancer. 2017. PMID: 28707167
Lung Cancer in South Africa.
van Eeden R, Tunmer M, Geldenhuys A, Nayler S, Rapoport BL. van Eeden R, et al. J Thorac Oncol. 2020 Jan;15(1):22-28. doi: 10.1016/j.jtho.2019.06.032. J Thorac Oncol. 2020. PMID: 31864550 Free article. No abstract available.
Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer.
Rapoport BL, Theron AJ, Vorobiof DA, Langenhoven L, Hall JM, Van Eeden RI, Smit T, Chan SW, Botha MC, Raats JI, Necker M, Anderson R. Rapoport BL, et al. Among authors: van eeden ri. Lung Cancer Manag. 2020 Jul 20;9(3):LMT37. doi: 10.2217/lmt-2020-0014. Lung Cancer Manag. 2020. PMID: 32774468 Free PMC article.
11 results